Our previous study also suggested that prostate cancer cells with the highest expression of PAK‐1 (DU‐145) as well as the breast cancer cells (MCF‐7) were the least susceptible to IPA‐318, raising the concern that the toxicity of IPA‐3 may not be dependent on PAK‐1 expression. The gene discussed is PAK1; the disease is prostate carcinoma.